Financial Performance - The company's operating revenue for 2022 was CNY 1,709,170,519, representing a 12.59% increase compared to CNY 1,518,111,081 in 2021[20] - The net profit attributable to shareholders for 2022 was CNY 99,229,330.76, a decrease of 13.51% from CNY 114,725,344.99 in 2021[20] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 97,157,650.60, down 2.48% from CNY 99,624,503.09 in 2021[20] - Basic earnings per share decreased by 13.89% to CNY 0.62 in 2022 from CNY 0.72 in 2021[21] - Diluted earnings per share fell by 15.28% to CNY 0.61 in 2022 compared to CNY 0.72 in 2021[21] - Operating profit decreased by 23.94% to CNY 10,174,820, down from CNY 13,377,560 in the previous year[49] - The company's gross profit margin decreased by 3.4% due to a 17.35% increase in main business costs, which reached CNY 1,424,263,004[51] Cash Flow and Assets - The net cash flow from operating activities increased significantly to CNY 185,450,042.47, a 210.33% rise from CNY 59,758,888.25 in 2021[20] - The total assets of the company at the end of 2022 were CNY 2,667,197,386.94, reflecting a 33.85% increase from CNY 1,992,675,036.08 at the end of 2021[20] - The net assets attributable to shareholders increased to CNY 1,599,453,072.35, a 12.58% rise from CNY 1,420,679,028.35 in 2021[20] - The company's total financial assets increased from CNY 311.56 million at the beginning of the year to CNY 371.90 million by year-end, reflecting a change of CNY 60.34 million[29] - The company's cash and cash equivalents at the end of the period were approximately ¥705.04 million, a 93.32% increase from the previous year[67] Investments and Subsidiaries - The company established Jiangsu Fengshan Quannuo New Energy Technology Co., Ltd. in August 2022, planning to invest in a project with an annual production capacity of 100,000 tons of battery electrolyte[31] - In September 2022, the company set up Hubei Fengshan New Materials Co., Ltd. to develop high-end fine chemical materials, with a planned production capacity of 130,000 tons of para-chlorotoluene[31] - The company has established a wholly-owned subsidiary, Jiangsu Fengshan Biochemical Technology Co., Ltd., to strengthen its pesticide sector and enhance operational efficiency[32] - The company has established three new wholly-owned subsidiaries in 2022, expanding its operational scope and market presence[60] - The company holds 100% equity in Hubei Fengshan and Fengshan Biochemical, indicating a strategic focus on full ownership in new ventures[100] Research and Development - The company has established a comprehensive R&D mechanism, focusing on high-efficiency, low-toxicity, and environmentally friendly pesticide raw materials and intermediates[41] - The company’s research and development expenses increased by 12.07% to CNY 49,456,459[50] - The company has established strong R&D capabilities, with 20 authorized invention patents and 2 utility model patents as of December 31, 2022, indicating robust innovation potential[46] - The company is committed to developing high-end fine chemical products, including chlorinated and fluorinated chemicals, to enhance product competitiveness[120] Market Trends and Competition - The lithium-ion electrolyte market is expected to face intensified competition in 2023, with companies possessing cost and technological advantages likely to stand out[39] - The agricultural sector is expected to see a rise in pesticide production revenue from 228.06 billion to over 250 billion by 2025, indicating growth potential in the industry[74] - The agricultural chemical industry in China is undergoing consolidation, with government policies promoting mergers and acquisitions to increase industry concentration and competitiveness[114] - The electrolyte industry is shifting from capacity competition to R&D innovation competition, requiring manufacturers to develop new functional electrolyte solutions[119] Environmental Management - The company has made significant progress in environmental management, optimizing wastewater treatment processes to achieve high standards and low emissions[34] - The company has received multiple honors for its environmental efforts, including recognition as an advanced enterprise in environmental protection in Jiangsu Province[192] - The company has invested in pollution control facilities, enhancing the efficiency of "three wastes" treatment and reducing emissions[183] - The company has implemented a hazardous waste incineration system with a daily processing capacity of 25 tons, along with a 36 tons/day waste salt incinerator and a 60 tons/day liquid incinerator[186] Governance and Management - The company has established a governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and coordinated operations[132] - The board of directors comprises 9 members, including 3 independent directors, and has established specialized committees to provide professional opinions for decision-making[134] - The company has implemented a comprehensive investor relations management system, conducting multiple online performance briefings to enhance communication with investors[136] - The company plans to continue enhancing its governance structure and investor relations management to protect shareholders' rights and improve transparency[136] Future Outlook - The company provided a future outlook, projecting a revenue growth of 20% for the next fiscal year[146] - The company plans to accelerate the construction and implementation of three major industrial sectors in 2023, ensuring timely completion and operation of projects through synchronized recruitment and market development[123] - The company aims to enhance its core competitiveness in the high-end fine chemical industry, focusing on expanding raw materials, strengthening formulations, and refining new business areas[121]

Financial Performance - The company's operating revenue for Q1 2023 was ¥395,516,977.68, representing a decrease of 10.40% compared to the same period last year[4]. - The net profit attributable to shareholders was ¥10,385,354.62, down 65.99% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥5,053,350.10, a decline of 80.98% compared to the previous year[4]. - The basic earnings per share for the period was ¥0.06, reflecting a decrease of 68.42% year-on-year[4]. - Total operating revenue for Q1 2023 was ¥395,516,977.68, a decrease of 10.4% compared to ¥441,406,976.76 in Q1 2022[18]. - Net profit for Q1 2023 was ¥10,106,438.02, a decline of 66.9% from ¥30,534,902.58 in Q1 2022[19]. - Earnings per share for Q1 2023 were ¥0.06, compared to ¥0.19 in Q1 2022[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,734,177,151.27, an increase of 2.51% from the end of the previous year[5]. - Total assets increased to ¥2,734,177,151.27 in Q1 2023 from ¥2,667,197,386.94 in Q1 2022, reflecting a growth of 2.5%[16]. - Total liabilities rose to ¥1,104,516,111.41 in Q1 2023, up from ¥1,067,938,797.83 in Q1 2022, indicating an increase of 3.4%[16]. - The total assets of the company as of January 1, 2023, were 2,669,022,709.13 RMB, reflecting an increase from 2,667,197,386.94 RMB at the end of 2022[27]. - The company's total liabilities remained stable at 622,194,355.82 RMB for current liabilities as of January 1, 2023[28]. Cash Flow - The cash flow from operating activities was negative at -¥34,337,868.16, indicating a significant cash outflow[4]. - In Q1 2023, the company reported a net cash flow from operating activities of -34,337,868.16 RMB, an improvement from -117,559,973.13 RMB in Q1 2022[23]. - Total cash inflow from investment activities was 716,177,893.67 RMB, significantly higher than 198,248,341.42 RMB in the same period last year, resulting in a net cash flow from investment activities of 142,059,333.18 RMB[24]. - The company experienced a net increase in cash and cash equivalents of 102,272,809.30 RMB in Q1 2023, contrasting with a decrease of -95,472,615.50 RMB in Q1 2022[24]. Equity and Shareholder Information - The equity attributable to shareholders increased by 1.92% to ¥1,630,134,439.70 compared to the end of the previous year[5]. - The top shareholder, Yin Fengshan, holds 41.72% of the shares, indicating a strong control over the company[10]. - Total equity attributable to shareholders reached ¥1,599.45 million, reflecting a minor decrease of ¥70.49 thousand compared to the last report[29]. - The total equity, including minority interests, was reported at ¥1,599.26 million, a decrease of ¥70.49 thousand[29]. Operational Changes - The company reported a decrease in trading financial assets, which fell to CNY 100,464,126.73 from CNY 260,440,869.56, a decline of about 61.4%[14]. - The company experienced a 53.01% increase in accounts receivable, attributed to sales payments still within the credit period[7]. - The company’s profit margin was impacted by a decline in pesticide product prices and overall market conditions, leading to a 54.25% decrease in total profit[8]. - The company has announced several significant announcements regarding stock repurchase and fundraising projects during the reporting period[11]. - The company is actively engaging in market expansion and new product development as part of its strategic initiatives[11]. Research and Development - The company reported a decrease in research and development expenses to ¥8,469,002.33 in Q1 2023 from ¥12,316,781.49 in Q1 2022, a reduction of 31.5%[19]. Accounting Standards - The company has adopted new accounting standards effective January 1, 2023, which may impact financial reporting[25].

2022 年第三季度报告 证券代码：603810 证券简称：丰山集团 江苏丰山集团股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 | 年初至报告期末 | 年初至报告期 | | --- | --- | --- | --- | --- | | | | 比上年同 | | 末比上年同期 | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 366,145,145.38 | 19.03 | 1,383,610,134. ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥1,017,464,989.35, representing a 19.73% increase compared to ¥849,812,969.21 in the same period last year[20]. - The net profit attributable to shareholders decreased by 10.39% to ¥74,254,972.12 from ¥82,861,185.19 in the previous year[20]. - Basic earnings per share decreased by 11.54% to ¥0.46 from ¥0.52 in the same period last year[21]. - The weighted average return on equity decreased by 0.95 percentage points to 5.13% from 6.08% in the previous year[21]. - The company achieved operating revenue of RMB 1,017,464,989.35, representing a year-on-year growth of 19.73%[34]. - The net profit attributable to the parent company was RMB 74,255,000, a decrease of 10.39% compared to the previous year[34]. - The company reported a net profit of CNY 187.42 from Jiangsu Fengshan Agricultural Chemical Co., with total assets of CNY 22,379.12 million[52]. - The company reported a net profit of 58,095,912.00, indicating a stable performance[173]. - The total comprehensive income for the first half of 2022 was 77,061,128.4 RMB[181]. Cash Flow and Liquidity - The net cash flow from operating activities improved significantly, reaching ¥14,845,082.42, compared to a negative cash flow of ¥142,545,869.22 in the same period last year, marking a 110.41% increase[20]. - The company reported a cash inflow from investment activities of RMB 169,025,787.55 in the first half of 2022, compared to RMB 300,459,238.63 in the first half of 2021[157]. - The company's cash and cash equivalents at the end of the period were CNY 305,725,583.30, compared to CNY 204,992,637.72 at the end of the first half of 2021, reflecting an increase of approximately 49%[154]. - The company received CNY 59,106,782.76 in tax refunds, significantly higher than CNY 15,122,605.07 in the previous year, marking an increase of about 290%[152]. - Cash inflow from operating activities totaled RMB 679,431,148.17 in the first half of 2022, compared to RMB 456,055,608.20 in the first half of 2021, reflecting a year-over-year increase of approximately 48.9%[157]. Assets and Liabilities - The total assets of the company increased by 14.72% to ¥2,285,954,433.39 from ¥1,992,675,036.08 at the end of the previous year[20]. - The total liabilities increased to ¥713,388,411.42, compared to ¥538,455,623.18 in the previous year, reflecting a growth of 32.5%[144]. - The company's total liabilities reached CNY 818,866,438.48, up from CNY 571,996,007.73 at the beginning of the period[137]. - The company's total equity reached CNY 1,467,087,994.91, up from CNY 1,420,679,028.35 at the beginning of the period[137]. - The company's intangible assets increased by 73.34% to CNY 91,837,104.08, attributed to land use rights acquisition[43]. Production and Operations - The company has established a comprehensive production and sales model centered around herbicides, insecticides, and fungicides, with key products including Fluazifop, Quizalofop, and Chlorpyrifos[27]. - The company’s production capacity for its new products, including Triclopyr and Cyhalofop-butyl, was launched during the reporting period[27]. - The company’s product structure includes fine chemical intermediates, pesticide active ingredients, and formulations, ensuring a stable supply chain for its operations[31]. - The company has been actively managing supply chain challenges due to rising raw material prices and logistics disruptions caused by the pandemic[36]. - The company is enhancing its production processes while ensuring compliance with safety and environmental regulations[36]. Environmental and Regulatory Compliance - The company has received various environmental accolades, including being recognized as a "Jiangsu Province Advanced Environmental Protection Enterprise"[29]. - The company has invested in pollution control facilities, enhancing the efficiency of "three wastes" treatment and reducing emissions[68]. - The company has installed online monitoring equipment for wastewater discharge, ensuring real-time monitoring of COD, total phosphorus, ammonia nitrogen, and total nitrogen[69]. - The company has implemented a comprehensive emergency response plan for environmental incidents, which has been filed with local environmental authorities[71]. - The company continues to optimize production processes and strengthen environmental management to enhance clean production levels[68]. Shareholder and Equity Management - The company did not distribute profits or increase capital reserves during the reporting period[6]. - The company has committed to long-term holding of its shares and may consider reducing its holdings after a two-year lock-up period[83]. - The company will ensure that the share reduction price does not fall below the latest audited net asset value per share[83]. - The company has established a policy to return any illegal gains from share reductions to the issuer[85]. - The company’s major shareholders have pledged to strictly adhere to the profit distribution policy as outlined in the company's articles of association[98]. Research and Development - The company holds 18 authorized invention patents and 2 utility model patents as of June 30, 2022, indicating strong R&D capabilities[34]. - The company is increasing R&D investments to achieve product differentiation and integrate pesticide formulations, active ingredients, and intermediates[56]. - Research and development expenses for the first half of 2022 were ¥21,717,260.83, slightly down from ¥22,047,351.79 in the same period last year[144]. Market and Strategic Initiatives - The company has established partnerships with major multinational corporations, enhancing its market presence and collaboration opportunities[30]. - The company has been focusing on expanding its overseas market, resulting in significant growth in export business[36]. - The company plans to continue its investment in new technologies and product development to enhance competitive advantage[173].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 441,406,976.76, representing a decrease of 2.84% compared to the same period last year[5] - The net profit attributable to shareholders was CNY 30,534,902.58, down 39.39% year-on-year[5] - The net profit after deducting non-recurring gains and losses was CNY 26,563,165.16, a decline of 44.93% compared to the previous year[5] - The basic earnings per share were CNY 0.19, down 38.71% from the same period last year[5] - The weighted average return on equity was 2.13%, a decrease of 1.56 percentage points year-on-year[5] - Total operating revenue for Q1 2022 was CNY 441,406,976.76, a decrease of 2% compared to CNY 454,318,728.70 in Q1 2021[22] - Net profit for Q1 2022 was CNY 30,534,902.58, down 39.4% from CNY 50,375,579.42 in Q1 2021[23] - Earnings per share for Q1 2022 were CNY 0.19, compared to CNY 0.31 in Q1 2021[24] Cash Flow and Assets - The net cash flow from operating activities was negative at CNY -117,559,973.13, a significant decrease of 147.55% year-on-year[5] - The company's cash and cash equivalents decreased to RMB 281,869,129.23 from RMB 364,706,984.85[18] - Cash flow from operating activities showed a net outflow of CNY 117,559,973.13, worsening from a net outflow of CNY 47,489,648.54 in Q1 2021[27] - Cash inflow from investment activities was CNY 198,248,341.42, slightly up from CNY 197,262,676.09 in the previous year[27] - The net cash flow from investment activities was $22,309,734.30, a significant improvement compared to the previous year's negative cash flow of -$193,427,492.25[28] - The ending balance of cash and cash equivalents was $214,427,299.75, down from $323,104,204.94 in the prior year[28] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,088,600,663.62, an increase of 4.81% from the end of the previous year[6] - The total current liabilities increased to RMB 592,119,247.84 from RMB 529,662,101.28[19] - Total liabilities increased to CNY 636,947,805.29, compared to CNY 571,996,007.73 in the previous year, reflecting a growth of 11.3%[20] - The total equity attributable to shareholders rose to CNY 1,451,652,858.33, up from CNY 1,420,679,028.35, marking a 2.2% increase[20] Shareholder Information - The total number of common shareholders at the end of the reporting period was 14,351[12] - The largest shareholder, Yin Fengshan, holds 67,725,478 shares, representing 41.7% of the total shares[12] Operational Changes - The company reported a significant increase in accounts receivable by 98.59%, primarily due to sales with outstanding payment terms[8] - Financial expenses surged by 105.82%, mainly attributed to fluctuations in the USD exchange rate[8] - The company plans to upgrade its production line to increase capacity to 1,700 tons of active ingredients and 1,083 tons of by-products[14] - The company has made strategic adjustments to its fundraising projects, focusing on optimizing production processes and capacity[14] Inventory and Expenses - The company's inventory increased to RMB 393,959,301.20 from RMB 343,560,393.05, indicating a rise in stock levels[18] - Total operating costs increased to CNY 404,894,862.17, up 3.2% from CNY 391,714,150.25 in the same period last year[22] - Research and development expenses for Q1 2022 were CNY 12,316,781.49, an increase of 21.6% from CNY 10,130,613.97 in Q1 2021[23] - The company reported a decrease in sales expenses to CNY 12,249,632.55 from CNY 9,481,025.26 in the previous year, indicating a 29.5% increase[23] Accounting Practices - The company did not apply the new accounting standards starting from 2022, indicating a continuation of previous accounting practices[28]

Financial Performance - The company's operating revenue for 2021 was CNY 1,518,111,081.32, representing a year-on-year increase of 1.61% compared to CNY 1,494,085,529.04 in 2020[22] - The net profit attributable to shareholders for 2021 was CNY 114,725,344.99, a decrease of 51.32% from CNY 235,683,496.73 in 2020[22] - The net profit after deducting non-recurring gains and losses was CNY 99,624,503.09, down 54.57% from CNY 219,296,974.47 in 2020[22] - The cash flow from operating activities for 2021 was CNY 59,758,888.25, a decrease of 62.05% compared to CNY 157,462,098.45 in 2020[22] - Basic earnings per share decreased by 52.00% to CNY 0.72 compared to CNY 1.50 in 2020[24] - Operating profit decreased by 52.36% to CNY 13,377,560.00 from CNY 28,080,210.00 in the previous year[46] - The company reported a net cash flow from operating activities of CNY 5,975,890.00, down 62.05% from CNY 15,746,210.00[46] - The gross profit margin for the main business decreased by 10.51 percentage points, with a gross profit margin of 20.04%[48] Assets and Liabilities - As of the end of 2021, the total assets were CNY 1,992,675,036.08, a slight decrease of 0.22% from CNY 1,996,996,595.29 at the end of 2020[23] - The net assets attributable to shareholders increased by 6.10% to CNY 1,420,679,028.35 from CNY 1,339,038,437.18 at the end of 2020[23] - The company's cash and cash equivalents decreased by 43.39%, from ¥644,221,917.06 to ¥364,706,984.85[64] - The company's investment activities resulted in a net cash outflow of CNY 242,369,164.27, a decline of 430.08% from the previous year[47] Market and Production - The company reported a pesticide production volume of 2,498,000 tons in 2021, indicating a recovery in the industry after a decline from 2016 to 2018[37] - The sales volume of herbicides decreased by 6.19%, while the production volume increased by 10.46%[53] - The domestic market contributed CNY 1,095,401,598.83 in revenue, with a gross profit margin of 20.66%, down 6.03 percentage points year-on-year[51] - The total cost of pesticides for the period reached ¥1,213,520,528.18, an increase of 17.12% compared to ¥1,036,090,245.23 in the same period last year[57] Research and Development - Research and development expenses decreased by 7.50% to CNY 44,129,971.04 from CNY 47,709,545.05[47] - The number of R&D personnel is 167, accounting for 12.31% of the total workforce[61] - The company has established a high-efficiency R&D system centered on customer needs, leading to successful trial production of new products[38] - The company is committed to increasing R&D investment to differentiate its products and enhance competitiveness in the agricultural chemical market[111] Environmental and Sustainability Initiatives - The company is focusing on sustainable development and enhancing safety and environmental standards in its operations[33] - The company has invested in environmental protection facilities, including wastewater biochemical treatment systems with capacities of 2000m³/d, 4000m³/d, and 4800m³/d, to ensure compliance with discharge standards[159] - The company has been recognized as an "Advanced Environmental Protection Enterprise" in Jiangsu Province and a "Friendly Environmental Enterprise" in Yancheng City[166] - The company has established a real-time monitoring system for wastewater discharge, ensuring compliance with chemical oxygen demand (COD), total phosphorus (TP), ammonia nitrogen (NH3-N), and total nitrogen (TN) standards[159] Corporate Governance - The company has established a governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and coordinated operations[115] - The board of directors comprises 9 members, including 3 independent directors, and has established specialized committees to provide scientific and professional opinions for decision-making[117] - The company has implemented a comprehensive investor relations management strategy, enhancing communication with investors and improving governance levels[118] - The company strictly adheres to information disclosure regulations, with the chairman as the primary responsible person for disclosures, ensuring timely and equal access to information for all shareholders[118] Shareholder Information - The total number of shares held by the chairman, Yin Fengshan, increased from 48,375,341 to 67,725,478, a change of 19,350,137 shares due to dividend distribution and transfer[123] - The company has implemented a share repurchase and cancellation strategy, resulting in a reduction of 28,000 shares held by supervisor Wang Li[125] - The company has a clear and transparent cash dividend policy, ensuring compliance with relevant regulations and shareholder interests[149] - The company plans to distribute a cash dividend of 1.77 RMB per 10 shares to all shareholders, based on the total share capital as of the dividend record date[148] Strategic Plans and Future Outlook - The company aims to strengthen its market share in pesticide raw materials while expanding its pesticide formulations and fine chemical intermediates[33] - The company is focusing on investment opportunities in new chemical materials and renewable energy sectors to achieve long-term growth and diversification[108] - The company plans to accelerate the construction of the Sichuan Guang'an base and the production line upgrades for various products, including 1,700 tons of active ingredients and 1,600 tons of intermediates annually[109] - The company provided a forward guidance of 10% revenue growth for the next quarter, projecting revenues of approximately $550 million[130]

2021 年第三季度报告 证券代码：603810 证券简称：丰山集团 江苏丰山集团股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告 期末比上年 | | --- | --- | --- | --- | --- | | | | 期增减变 | 年初至报告期末 | 同期增减变 | | | | 动幅度(%) | | 动幅度(%) | | 营业收入 | 307,606,106.44 | 38.20 | 1,157,419,075.65 | 5. ...

Financial Performance - The company's operating revenue for the first half of 2021 was approximately ¥849.81 million, a decrease of 3.16% compared to ¥877.55 million in the same period last year[17]. - The net profit attributable to shareholders for the first half of 2021 was approximately ¥82.86 million, down 48.52% from ¥160.96 million in the previous year[17]. - The basic earnings per share for the first half of 2021 was ¥0.52, a decline of 62.59% compared to ¥1.39 in the same period last year[19]. - The net cash flow from operating activities was negative at approximately -¥142.55 million, a decrease of 223.66% compared to ¥115.27 million in the previous year[18]. - The total operating revenue for the first half of 2021 was ¥849,812,969.21, a decrease of 3.16% compared to ¥877,548,279.67 in the previous year[47]. - Operating costs increased by 11.94% to CNY 661,643,505.85 from CNY 591,073,814.69 in the previous year[47]. - The company's cash and cash equivalents decreased by 56.55% to CNY 279,890,204.53 from CNY 644,221,917.06 in the previous year[47]. - The company's net profit for the first half of 2021 was CNY 77,061,128.47, a decrease from CNY 162,515,150.93 in the same period of 2020, representing a decline of approximately 52.6%[155]. Assets and Liabilities - The total assets at the end of the reporting period were approximately ¥2.01 billion, an increase of 0.50% from ¥1.99 billion at the end of the previous year[18]. - The net assets attributable to shareholders at the end of the reporting period were approximately ¥1.37 billion, an increase of 2.09% from ¥1.34 billion at the end of the previous year[18]. - The total assets at the end of the reporting period amounted to 162,676,080.00 RMB, indicating growth in the company's asset base[186]. - Total liabilities decreased to ¥639,801,859.78 from ¥657,958,158.11, a decline of about 2.4%[144]. - Current liabilities decreased to ¥595,097,882.33 from ¥622,705,373.57, a reduction of about 4.4%[144]. - Non-current liabilities increased to ¥44,703,977.45 from ¥35,252,784.54, representing a rise of approximately 27%[144]. Research and Development - The company has established a comprehensive R&D system, with ongoing investments in technology innovation, leading to a competitive edge in the agricultural pesticide sector[34]. - Research and development expenses rose by 15.53% to CNY 22,047,351.79 from CNY 19,083,730.87 in the previous year[47]. - The company plans to increase R&D investment to achieve product differentiation and enhance its comprehensive competitiveness in the pesticide industry[61]. - The company is investing heavily in R&D, with a budget increase of 30% to enhance technology development and innovation[93]. Market Strategy and Competition - The company focuses on the research, production, and sales of environmentally friendly pesticides, with a core business in herbicides supplemented by insecticides and fungicides[25]. - The sales strategy combines direct sales and distribution, allowing the company to quickly respond to market demands and reduce costs[28]. - The global pesticide market has seen a slowdown, maintaining an annual growth rate of around 4% since 2015, with demand driven by agricultural profitability and environmental regulations[29]. - The pesticide industry is undergoing consolidation, with major global players engaging in mergers and acquisitions to strengthen their market positions[30]. - The company aims to expand its market share by optimizing resource allocation and continuously developing new products[28]. Environmental and Safety Compliance - The company has maintained a strong focus on safety production, adhering to national safety regulations and achieving zero major safety incidents during the reporting period[32]. - The company has invested over 90% of hazardous waste for self-disposal, ensuring efficient treatment and compliance with environmental standards[33]. - The company emphasizes strict compliance with safety and environmental regulations to avoid production halts or penalties, ensuring stable operations[60]. - The company has received multiple safety and environmental management certifications, including ISO14001:2015 and ISO45001:2018, ensuring compliance with quality management standards[39]. Shareholder and Governance - The company did not distribute profits or increase capital reserves during the reporting period[4]. - The company has established a lock-up period for shareholders, limiting share transfers to 25% of their holdings annually for a period of two years post-lock-up[99]. - The company’s board members and senior management are required to report their shareholdings and any changes during their tenure[99]. - The company reported a reduction in shareholding by Jiangsu Gaotou Ningtai, which amounted to 1,230,400 shares, representing a 1.06% decrease in total shares held[103]. Future Outlook - The company provided an optimistic outlook for the second half of 2021, projecting a revenue growth of 25%[95]. - New product launches are expected to contribute an additional 300 million in revenue by the end of the year[96]. - The company plans to enhance service frequency to end-users and introduce new product development and sales talent[44]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[182].

Financial Performance - Net profit attributable to shareholders decreased by 40.12% to CNY 50,375,579.42 year-on-year[8] - Total profit decreased by 39.02% to CNY 60,009,839.28, mainly due to a decline in sales gross margin[13] - Basic earnings per share dropped by 57.43% to CNY 0.43[8] - Net profit for Q1 2021 was CNY 50,375,579.42, a decrease of 40.19% compared to CNY 84,120,583.20 in Q1 2020[28] - Operating profit for Q1 2021 was ¥64.36 million, down 37.47% from ¥102.87 million in Q1 2020[31] - Net profit for Q1 2021 was ¥54.32 million, a decline of 37.00% compared to ¥86.25 million in Q1 2020[31] Revenue and Costs - Operating revenue increased slightly by 0.82% to CNY 454,318,728.70 compared to the same period last year[8] - Total operating revenue for Q1 2021 was CNY 454,318,728.70, a slight increase of 0.15% compared to CNY 450,623,121.84 in Q1 2020[27] - Total operating costs increased to CNY 391,714,150.25, up 13.14% from CNY 346,177,246.22 in the same period last year[27] - The company's operating revenue for Q1 2021 was ¥383.30 million, a decrease of 2.37% compared to ¥393.23 million in Q1 2020[30] Cash Flow and Liquidity - Cash flow from operating activities showed a significant decline of 165.98%, resulting in a net outflow of CNY 47,489,648.54[8] - The cash flow from operating activities showed a net outflow of CNY 47,489,648.54, a decrease of 165.98% compared to the previous year[15] - Cash flow from operating activities reflects the company's ability to generate cash from its core business operations[39] - The company maintained a healthy cash position, which is crucial for future investments and operational stability[39] - The company reported a significant increase in cash and cash equivalents, indicating strong liquidity management[39] Assets and Liabilities - Total assets increased by 4.02% to CNY 2,077,228,615.85 compared to the end of the previous year[8] - The total current liabilities decreased by 32.24% to CNY 35,692,550.68, primarily due to a reduction in advance payments from customers[14] - The accounts payable decreased to CNY 160,780,022.09, down from CNY 167,712,860.43, indicating improved cash management[19] - Total liabilities increased to CNY 606,451,824.02, up 3.41% from CNY 586,582,585.19[23] Shareholder Information - The number of shareholders reached 12,056 at the end of the reporting period[10] Tax and Refunds - The company received tax refunds amounting to CNY 13,054,941.72, representing a 251.15% increase year-on-year due to increased export tax rebates[14] - The company received ¥13.05 million in tax refunds during Q1 2021, compared to ¥3.72 million in Q1 2020, showing improved cash flow management[35] Research and Development - The company reported a significant increase in research and development expenses to CNY 10,130,613.97, up from CNY 9,284,010.12, reflecting a focus on innovation[27] - Research and development expenses increased to ¥10.08 million in Q1 2021, compared to ¥9.31 million in Q1 2020, reflecting a focus on innovation[30] Other Financial Metrics - The weighted average return on net assets decreased by 3.66 percentage points to 3.69%[8] - Sales expenses decreased by 38.41% to CNY 9,481,025.26, attributed to the reclassification of shipping and export fees[13] - The company reported a significant increase in other current liabilities, which rose by 70.72% to CNY 86,641,854.16, attributed to increased provisions for sales of formulation products[14] - The deferred income tax liabilities increased by 70.42% to CNY 2,161,944.95, primarily due to an increase in estimated return costs for new formulation sales[14] Cash Management - The cash paid for purchasing goods and services was CNY 195,214,883.51, a 79.56% increase compared to the previous year, mainly due to the payment of matured bank drafts[15] - The company’s cash and cash equivalents decreased to CNY 415,694,343.10 from CNY 644,221,917.06, indicating a liquidity contraction[17] Financial Reporting - The financial report did not include any audit report, indicating that the financials were not subject to external audit scrutiny[40] - The company did not apply the new lease accounting standards for the first quarter of 2021[40]

Financial Performance - The company's operating revenue for 2020 was approximately ¥1.49 billion, representing a year-on-year increase of 72.58% compared to ¥865.76 million in 2019[21]. - Net profit attributable to shareholders reached approximately ¥235.68 million, a significant increase of 578.05% from ¥34.76 million in 2019[21]. - Basic earnings per share rose to ¥2.10, up 388.37% from ¥0.43 in 2019[22]. - The weighted average return on equity increased to 19.42%, up 16.27 percentage points from 3.15% in 2019[22]. - The total assets of the company at the end of 2020 were approximately ¥1.997 billion, reflecting a 29.77% increase from ¥1.539 billion at the end of 2019[21]. - The company reported a significant increase in cash and cash equivalents by CNY 267.62 million, mainly due to the redemption of financial products[35]. - The company reported a total revenue of RMB 149,167.88 million, representing a year-on-year increase of 72.36%[104]. - Domestic sales accounted for RMB 100,649.93 million, with a growth of 51.12%, while export sales surged by 143.30% to RMB 48,517.96 million[104]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of RMB 5.00 per 10 shares, totaling RMB 58,116,800.00, which represents 24.66% of the net profit attributable to shareholders[5]. - The profit distribution policy prioritizes cash dividends, with a minimum distribution of 10% of the available profit for the year, and cumulative distributions over three years should not be less than 30% of the average annual distributable profit[142]. - The company has maintained a stable dividend payout ratio, with a focus on balancing shareholder returns and reinvestment for growth[150]. - The total cash dividends distributed over the last three years amounted to RMB 11,057.54 million, reflecting a consistent return to shareholders[150]. - The company’s cash dividend policy has been executed transparently, with detailed announcements made prior to implementation[147]. Operational Developments - The company completed the construction and installation of new production lines for several products, including 1,000 tons of Triclopyr and 700 tons of Cyhalofop-butyl, which are now entering trial production[30]. - A new formulation division was established to enhance the market influence of the company's products, separating production, procurement, and sales from the previous unified management model[30]. - The company has formed a sales model combining direct sales and distribution, with direct sales primarily for raw materials, enhancing brand influence and market responsiveness[33]. - The company has developed a robust marketing network across multiple cities in China and established stable sales channels in international markets, enhancing sales scale and risk resilience[42]. Research and Development - The company has established a comprehensive R&D system, supported by various research platforms, and continues to invest in technology innovation[40]. - Research and development expenses increased by 10.02% to 47.7 million yuan, reflecting the company's commitment to innovation[53]. - The company has filed 2 new patent applications during the reporting period, enhancing its innovation capabilities[89]. - The company has been actively pursuing technological innovation, achieving significant improvements in production processes that enhance safety and reduce costs[89]. Environmental and Compliance - The company emphasizes environmental protection, achieving over 90% self-disposal of hazardous waste and maintaining compliance with environmental standards[38]. - The construction of the Sichuan Guang'an base project will enhance the company's investment in environmental protection and ensure sustainable development[38]. - The implementation of the new Solid Waste Law is expected to enhance environmental compliance and reshape market competition in the chemical industry[74]. - The company has received multiple safety and environmental certifications, ensuring compliance and enhancing operational stability[43]. Financial Management - The company has successfully completed multiple financial products with returns ranging from 2.80% to 7.00%[192]. - The company is actively managing a diverse portfolio of financial products with varying risk profiles and returns[192]. - The company has reported a successful track record of achieving expected returns across multiple financial products[192]. - The company has engaged in various asset management plans, with expected returns between 5.8% and 6.5%[192]. Strategic Goals and Future Plans - The company aims to enter the top 20 in China's agricultural chemical industry by 2025, focusing on original drug and formulation business growth[119]. - The company plans to enhance production management and expand production scale while reducing costs through automation and process upgrades[120]. - The company is committed to sustainable development, emphasizing safety and environmental protection as foundational principles[122]. - The company will continue to invest in research and development to achieve product differentiation and enhance competitiveness in the agricultural chemicals market[129]. Risk Management - The company has outlined potential risks in its future development plans, which investors should be aware of[8]. - The company faces risks related to regulatory policy changes, which could impact production and operational costs[127]. - The company is addressing the risk of raw material price fluctuations by closely monitoring market changes and optimizing procurement strategies[130].